Status:
COMPLETED
The POUR (Postoperative Urinary Retention) Study
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Postoperative Urinary Retention
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary aim of this study will be to compare the rate of postoperative urinary retention between patients receiving Sugammadex and those receiving traditional reversal agents
Detailed Description
Postoperative urinary retention following laparoscopic inguinal hernia repair occurs in approximately one out of ten patients. The more rapid reversal of neuromuscular blockade with Sugammadex has emp...
Eligibility Criteria
Inclusion
- Over the age of 18
- Undergoing laparoscopic inguinal hernia repair at Carolinas Medical Center by attending surgeons within the Division of Gastrointestinal and Minimally Invasive Surgery
- Unilateral or bilateral inguinal hernia repair; may have concurrent umbilical hernia repair performed
- Agreeable to participation in the study
Exclusion
- Patients who are having concurrent ventral or flank hernias repaired at time of operation or are having an inguinal hernia repair along with another operation (e.g.
- laparoscopic cholecystectomy)
- End-stage renal disease (Creatinine clearance less than 30)
- Neuromuscular disease
- Prior adverse reactions to Sugammadex
- Patients who do not provide consent for the study
Key Trial Info
Start Date :
April 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 3 2024
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT05276804
Start Date
April 13 2022
End Date
September 3 2024
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carolinas Medical Center
Charlotte, North Carolina, United States, 28204